Our Services
Medical Information
Helpful Resources
Published on: 10/11/2026
High monocytes, known as monocytosis, can occasionally signal a blood cancer such as chronic myelomonocytic leukemia or acute monocytic leukemia, but far more often it reflects infections, autoimmune conditions, recovery from illness, chronic inflammation, or stress on the bone marrow. Leukemia is usually suspected only when monocyte elevation is persistent and paired with other abnormal results, such as low red blood cells or platelets, very high white cell counts, or immature cells on a blood smear, along with symptoms like unexplained fatigue, fevers, night sweats, weight loss, easy bruising, or an enlarged spleen. The degree of elevation, how long it lasts, your medications, and your overall clinical picture all change what the number means, so there are several important factors to consider before drawing conclusions. See below to understand more about common causes, warning signs, and the follow-up testing doctors typically order.
Because a single lab value rarely tells the whole story, the fastest way to put your result in context is to review your symptoms systematically rather than guess, so take a free, instant, online symptom check to see which explanations best fit your situation and what questions to raise with your doctor next.
Last reviewed for medical accuracy: 10/09/2026
A blood test that shows an elevated monocyte count—called monocytosis—can have many causes. One question that naturally arises is: “Could this be leukemia?” While certain leukemias are indeed associated with high monocyte levels, most cases of monocytosis turn out to be infections, inflammation or other benign conditions. This article will help you understand:
Monocytes are a type of white blood cell (WBC) that play a key role in your immune system. They:
Laboratories report monocytes in two ways:
A result higher than these ranges is called monocytosis.
In leukemias with a monocytic component—such as chronic myelomonocytic leukemia (CMML) or acute monocytic leukemia (French–American–British classification M5)—monocyte counts can be strikingly elevated:
By contrast, mild monocytosis (e.g. 0.9–1.5 × 10^9/L) is far more commonly due to infections or inflammation.
Before jumping to a leukemia diagnosis, consider other frequent reasons for a high monocyte count:
• Infections
– Subacute or chronic infections (tuberculosis, syphilis, endocarditis)
– Viral illnesses (mononucleosis, cytomegalovirus)
• Inflammatory and Autoimmune Conditions
– Inflammatory bowel disease
– Rheumatoid arthritis, lupus
• Recovery Phase of Acute Infections
– Monocytes often rise as neutrophils fall
• Stress Responses
– Corticosteroid use
– Physical stress (trauma, surgery)
• Other Blood Disorders
– Myelodysplastic syndromes
– Chronic myelogenous leukemia (rarely features monocytosis as a main finding)
Leukemia should be considered when monocytosis is marked and accompanied by other worrying features:
If your blood test shows monocytes well above 1 × 10^9/L or monocytes make up more than 10% of total WBC, and you have any of the above signs, further evaluation is warranted.
• Night sweats and unintentional weight loss
• Frequent infections despite treatment
• Bone pain or tenderness
• Lymph node enlargement
These symptoms do not prove leukemia, but they do signal that you and your doctor should investigate further.
If your monocyte count is raised, here are the usual steps:
Throughout this process, your physician will integrate your symptoms, exam findings and lab results to guide testing.
• Keep a symptom diary
– Note fevers, night sweats, bruising, bleeding or new lumps
• Share your medication list
– Some drugs (like steroids) can transiently raise monocytes
• Ask about a free, online symptom check, using the doctor approved Ubie Symptom Checker
• link: https://ubiehealth.com/
Monocytosis alone is rarely a medical emergency. But if you experience:
…seek medical attention promptly or call emergency services. These could be signs of complications that need immediate treatment.
Monocytosis can understandably cause concern, especially given the possibility of a blood cancer diagnosis. However:
Working closely with your doctor, you can identify whether your monocytosis stems from a benign process or requires further hematologic investigation.
If your blood tests show high monocytes—especially if the count is markedly elevated or you have other concerning symptoms—talk with your healthcare provider as soon as possible. Only a qualified physician can interpret your individual results in context and recommend the right next steps.
(References)
* Thiel E. Cell surface markers in leukemia: biological and clinical correlations. Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. PMID: 3013441.
* Schmalzl F. Acute monocytic leukemias. Haematol Blood Transfus. 1981;27:145-56. doi: 10.1007/978-3-642-81696-3_16. PMID: 6948754.
* Shaw MT. Monocytic leukemias. Hum Pathol. 1980 May;11(3):215-27. doi: 10.1016/s0046-8177(80)80003-7. PMID: 6995269.
* Raskin RE. Myelopoiesis and myeloproliferative disorders. Vet Clin North Am Small Anim Pract. 1996 Sep;26(5):1023-42. doi: 10.1016/s0195-5616(96)50054-9. PMID: 8863389.
* Zeng Z, Sarbassov dos D, Samudio IJ, Yee KW, Munsell MF, Ellen Jackson C, Giles FJ, Sabatini DM, Andreeff M, Konopleva M. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood. 2007 Apr 15;109(8):3509-12. doi: 10.1182/blood-2006-06-030833. Epub 2006 Dec 19. PMID: 17179228; PMCID: PMC1852241.
* Matarraz S, Almeida J, Flores-Montero J, Lécrevisse Q, Guerri V, López A, Bárrena S, Van Der Velden VHJ, Te Marvelde JG, Van Dongen JJM, Orfao A. Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry. Cytometry B Clin Cytom. 2017 May;92(3):218-227. doi: 10.1002/cyto.b.21219. Epub 2015 Aug 18. PMID: 26282340.
* Solary E, Itzykson R. How I treat chronic myelomonocytic leukemia. Blood. 2017 Jul 13;130(2):126-136. doi: 10.1182/blood-2017-04-736421. Epub 2017 Jun 1. PMID: 28572287.
* Fong JY, Pignata L, Goy PA, Kawabata KC, Lee SC, Koh CM, Musiani D, Massignani E, Kotini AG, Penson A, Wun CM, Shen Y, Schwarz M, Low DH, Rialdi A, Ki M, Wollmann H, Mzoughi S, Gay F, Thompson C, Hart T, Barbash O, Luciani GM, Szewczyk MM, Wouters BJ, Delwel R, Papapetrou EP, Barsyte-Lovejoy D, Arrowsmith CH, Minden MD, Jin J, Melnick A, Bonaldi T, Abdel-Wahab O, Guccione E. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. Cancer Cell. 2019 Aug 12;36(2):194-209.e9. doi: 10.1016/j.ccell.2019.07.003. PMID: 31408619; PMCID: PMC7194031.
* Waclawiczek A, Hamilton A, Rouault-Pierre K, Abarrategi A, Albornoz MG, Miraki-Moud F, Bah N, Gribben J, Fitzgibbon J, Taussig D, Bonnet D. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia. J Clin Invest. 2020 Jun 1;130(6):3038-3050. doi: 10.1172/JCI133187. PMID: 32364536; PMCID: PMC7260026.
* Puissant A, Medyouf H. Walking the Tightrope: Balancing Delicate Inflammation Response to Eradicate Acute Myeloid Leukemia. Cancer Discov. 2022 Jul 6;12(7):1617-1619. doi: 10.1158/2159-8290.CD-22-0473. PMID: 35791696.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.